000 01156 a2200313 4500
005 20250515135707.0
264 0 _c20080930
008 200809s 0 0 eng d
022 _a1537-2677
024 7 _a10.1097/IOP.0b013e3181829f7b
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGarrity, James A
245 0 0 _aBiologic response modifiers for ophthalmologists.
_h[electronic resource]
260 _bOphthalmic plastic and reconstructive surgery
_c
300 _a345-7 p.
_bdigital
500 _aPublication Type: Comment; Journal Article
650 0 4 _aAnti-Inflammatory Agents
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aDacryocystitis
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aImmunologic Factors
_xtherapeutic use
650 0 4 _aInflammation
_xdrug therapy
650 0 4 _aInfliximab
650 0 4 _aOphthalmology
650 0 4 _aOrbital Pseudotumor
_xdrug therapy
700 1 _aMatteson, Eric L
773 0 _tOphthalmic plastic and reconstructive surgery
_gvol. 24
_gno. 5
_gp. 345-7
856 4 0 _uhttps://doi.org/10.1097/IOP.0b013e3181829f7b
_zAvailable from publisher's website
999 _c18274321
_d18274321